SEC Form 4 · accession 0001209191-15-019541
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua S Boger
Director
Period of report
Feb 25, 2015
Accepted (ET)
Feb 27, 2015 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2015 | G | 2,500 | $0.00 | D | 336,395 | D | |
| Common Stock | Feb 25, 2015 | M | 1,300 | $17.16 | A | 337,695 | D | |
| Common Stock | Feb 25, 2015 | M | 10,400 | $35.64 | A | 348,095 | D | |
| Common StockF3,F4 | Feb 25, 2015 | S | 300 | $116.89 | D | 347,795 | D | |
| Common StockF4,F5 | Feb 25, 2015 | S | 7,300 | $118.66 | D | 340,495 | D | |
| Common StockF4,F6 | Feb 25, 2015 | S | 2,900 | $119.56 | D | 337,595 | D | |
| Common StockF4,F7 | Feb 25, 2015 | S | 1,200 | $120.58 | D | 336,395 | D | |
| Common StockF8 | holding | — | — | — | 372,111 | D | ||
| Common Stock | holding | — | — | — | 13,286 | I | 401(k) | |
| Common StockF8,F9 | holding | — | — | — | 136,873 | I | Common Stock held in trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F10 | $17.16 | Feb 25, 2015 | M | 1,300 | D | — | Jul 19, 2015 | Common Stock | 1,300 | 26,500 | D |
| Stock Option (right to buy)F10 | $35.64 | Feb 25, 2015 | M | 10,400 | D | — | Feb 1, 2016 | Common Stock | 10,400 | 500,000 | D |
Explanation of responses
- F1Represents a gift made to a charitable foundation.
- F10Fully vested.
- F2Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- F3Open market sales reported on this line occurred at a weighted average price of $116.89 (range $116.55 to $117.48).
- F4Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- F5Open market sales reported on this line occurred at a weighted average price of $118.66 (range $118.19 to $119.18).
- F6Open market sales reported on this line occurred at a weighted average price of $119.56 (range $119.19 to $120.15).
- F7Open market sales reported on this line occurred at a weighted average price of $120.58 (range $120.26 to $121.19).
- F8Reflects a change in the form of ownership resulting from a 2/26/2015 distribution of an aggregate of 35,716 shares from grantor retained annuity trusts to Dr. Boger.
- F9Common stock held in grantor retained annuity trusts.